Type I interferons (IFN) are widely used for the therapeutic treatment of viral infections, tumor growth and various chronic diseases such as multiple sclerosis. Antagonism between type I IFNs and IFN-␥ has been described in cells of the immune system, in particular in the activation of macrophages. To study the systemic effects of type I IFNs we used transgenic mice carrying a human IFN- (hIFN-) gene under the control of the rat insulin I promoter. These animals expressed high levels of hIFN- in -pancreatic cells, and the ability of the macrophages to respond to proinflammatory stimuli was analyzed. Transgenic mice exhibited an increased extravasation of cells to the peritoneal cav-